Breaking News, Collaborations & Alliances

Caris Partners with Merck KGaA, Darmstadt, Germany

Will work together to discover novel cancer targets and accelerate first-in-class antibody-drug conjugate development.

Author Image

By: Charlie Sternberg

Associate Editor

Caris Discovery, the therapeutic research arm of Caris Life Sciences, an AI TechBio company and precision medicine pioneer, has announced a multi-year strategic partnership with Merck KGaA, Darmstadt, Germany to accelerate the discovery and development of first-in-class antibody-drug conjugates (ADC) for cancer patients.   “We are thrilled to join forces with Merck KGaA, Darmstadt, Germany, to discover targets with the first-in-class potential to advance the next wave of transformational...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters